LASIK corrects residual error after multifocal IOL implantation

Article

Wavefront-guided LASIK is safe and effective in correcting residual refractive error after diffractive multifocal IOL implantation, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

Wavefront-guided LASIK is safe and effective in correcting residual refractive error after diffractive multifocal IOL implantation, according to a study published in the March 2008 issue of the Journal of Refractive Surgery.

Bettina B. Jendritza, MD and co-workers of the FreeVis LASIK Zentrum, Klinikum Mannheim, Germany investigated the use of wavefront-guided LASIK after multifocal IOL implantation to correct residual ametropia and higher order aberrations.

In a prospective, non-randomized case series, wavefront-guided LASIK was performed in 27 eyes (19 patients) after multifocal IOL (Tecnis; AMO, ReSTOR; Alcon and ReZoom; AMO) implantation using the VISX STAR S4 IR excimer laser (AMO). Visual acuity (VA), manifest refraction, and wavefront error were examined pre- and three months postoperatively.

In the Tecnis group (n=20), changes before and after LASIK, respectively, were: sphere +1.06±0.77D to -0.03±0.28D; cylinder -1.13±0.73D to -0.14±0.25D; distance uncorrected VA (UCVA) 20/45±0.09 to 20/29±0.16; near UCVA 20/30±0.24 to 20/25±0.16; higher order aberrations (4 mm pupil) 0.14±0.05 µm to 0.18±0.03 µm. Distance and near best spectacle-corrected visual acuity (BSCVA) did not change.

In the ReSTOR group (n=4), changes before and after LASIK, respectively, were: sphere +0.75±0.56D to +0.13±0.22D; cylinder -1.50±0.47D to -0.13±0.22D; distance UCVA 20/40±0.07 to 20/26±0.07; near UCVA 20/44±0.05 to 20/25±0.00; higher order aberrations (4 mm pupil) 0.14±0.03 µm to 0.20±0.02 µm. Distance and near BSCVA did not change.

In the ReZoom group (n=3), changes before and after LASIK, respectively, were: sphere +0.08±1.20D to 0.00D; cylinder -0.83±0.12D to 0.00D; distance UCVA 20/40±0 to 20/25±0; near UCVA 20/60±0.09 to 20/150±0.18; higher order aberrations (4 mm pupil) 0.43±0.04 µm to 0.39±0.03 µm. Patients lost one line of distance BSCVA and two lines of near BSCVA.

The researchers concluded that wavefront-guided LASIK is safe and effective in patients implanted with diffractive multifocal IOLs to correct residual refractive error, but higher order aberrations do not improve. It is not recommended in patients implanted with refractive multifocal IOLs, because of the lack of reliability of current wavefront sensors in this setting.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.